- Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
- Nordic Nanovector ASA: Allocation of PSUs
- Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL
- Nordic Nanovector ASA - Financial Calendar
- Nordic Nanovector ASA - Results for the Third Quarter 2019
- Nordic Nanovector to Participate in Four Upcoming Investor Conferences
- Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
- Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider
- Nordic Nanovector ASA - Resolution not to Proceed With a Repair Offering
- Nordic Nanovector ASA - Tranche 1 Share Capital Increase Registered
Nordic Nanovector ASA (8NN:FRA) closed at 2.74, 40.80% above the 52 week low of 1.95 set on Oct 25, 2019.
1.95Oct 25 20196.10Dec 14 2018
Markit short selling activity
|Market cap||1.61bn NOK|
|EPS (TTM)||-7.23 |
Data delayed at least 15 minutes, as of Dec 13 2019 07:23 GMT.